Ming Cheng

机构：First Affiliated Hospital of Zhengzhou University

发表论文 58 篇 · 总被引 1597 次 · h-index 19

代表论文

• Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3 (2015 · Journal of Biological Chemistry · 被引 116)
• Retargeting T Cells to GD2 Pentasaccharide on Human Tumors Using Bispecific Humanized Antibody (2014 · Cancer Immunology Research · 被引 97)
• Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy (2014 · International Journal of Cancer · 被引 52)
• RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway (2022 · Cell Communication and Signaling · 被引 45)
• Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy (2019 · Biomaterials Science · 被引 45)
• Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation via activation of AKT and is directly targeted by microRNA-494 in pancreatic cancer (2019 · World Journal of Gastroenterology · 被引 42)